Rami Hannoush is the founder of EpiBiologics. EpiBiologics has raised $50M in total funding. Latest round: Series A. Based in San Mateo, California.
Rami Hannoush is the CEO of EpiBiologics, a San Mateo, CA-based biotechnology company founded in 2022. EpiBiologics is developing a next-generation antibody-based protein degradation platform focusing on membrane and extracellular proteins. The company recently raised $50 million in Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library